There is mounting evidence of the oncogenic influence of ZIC2 expression in human cancers, and high expression of ZIC2 has been found in nasopharyngeal cancer, breast cancer, and prostate cancer [9–11]. This evidence concerns the gene ZIC2 and breast carcinoma.